{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:29:48Z","timestamp":1648859388439},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00120-021-01703-5","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T18:02:21Z","timestamp":1636048941000},"page":"13-17","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarkopenie: ein geriatrisches Syndrom mit Bedeutung f\u00fcr die Urologie"],"prefix":"10.1007","volume":"61","author":[{"given":"Hans J\u00fcrgen","family":"Heppner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"1703_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft\u00a0AJ, Sayer\u00a0AA (2019) Sarcopenia. Lancet 393:2636\u20132646","journal-title":"Lancet"},{"key":"1703_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00223-017-0277-0","volume":"101","author":"SC Shaw","year":"2017","unstructured":"Shaw\u00a0SC, Dennison\u00a0EM, Cooper\u00a0C (2017) Epidemiology of sarcopenia: determinants throughout the lifecourse. Calcif Tissue Int 101:229\u2013247","journal-title":"Calcif Tissue Int"},{"key":"1703_CR3","first-page":"188","volume":"10","author":"T M\u00fcnzer","year":"2010","unstructured":"M\u00fcnzer\u00a0T (2010) Sarkopenie im Alter. Schweiz Med Forum 10:188\u2013190","journal-title":"Schweiz Med Forum"},{"key":"1703_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1532-5415.2009.02681.x","volume":"58","author":"A Koster","year":"2010","unstructured":"Koster\u00a0A, Visser\u00a0M, Simonsick\u00a0EM et\u00a0al (2010) Association between fitness and changes in body composition and muscle strength. J\u00a0Am Geriatr Soc 58:219\u2013226","journal-title":"J Am Geriatr Soc"},{"key":"1703_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jamda.2014.02.002","volume":"15","author":"M Drey","year":"2014","unstructured":"Drey\u00a0M, Krieger\u00a0B, Sieber\u00a0CC et\u00a0al (2014) Motoneuron loss is associated with sarcopenia. J\u00a0Am Med Dir Assoc 15:435\u2013439","journal-title":"J Am Med Dir Assoc"},{"key":"1703_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clnu.2014.07.010","volume":"34","author":"G Sergi","year":"2015","unstructured":"Sergi\u00a0G, De Rui\u00a0M, Veronese\u00a0N et al (2015) Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr 34:667\u2013673","journal-title":"Clin Nutr"},{"key":"1703_CR7","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s11357-013-9517-z","volume":"35","author":"EM Strasser","year":"2013","unstructured":"Strasser\u00a0EM, Draskovits\u00a0T, Praschak\u00a0M et\u00a0al (2013) Association between ultrasound measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength in the elderly. Age 35:2377\u20132388","journal-title":"Age"},{"key":"1703_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2018","unstructured":"Cruz-Jentoft\u00a0AJ, Bahat\u00a0G, Bauer\u00a0J et al (2018) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:601\u2013609","journal-title":"Age Ageing"},{"key":"1703_CR9","doi-asserted-by":"publisher","first-page":"M320","DOI":"10.1093\/gerona\/53A.4.M320","volume":"53","author":"G Wu","year":"1998","unstructured":"Wu\u00a0G (1998) The relation between age-related changes in neuromusculoskeletal system and dynamic postural responses to balance disturbance. J Gerontol A Biol Sci Med Sci 53:M320\u2013326","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"1703_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.clnu.2012.02.007","volume":"31","author":"F Landi","year":"2012","unstructured":"Landi\u00a0F, Liperoti\u00a0R, Russo\u00a0A et\u00a0al (2012) Sarcopenia as a\u00a0risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31:652\u2013658","journal-title":"Clin Nutr"},{"key":"1703_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent\u00a0E, Morley\u00a0JE, Cruz-Jentoft\u00a0AJ et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J\u00a0Nutr Health Aging 22:1148\u20131161","journal-title":"J Nutr Health Aging"},{"key":"1703_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jamda.2019.12.011","volume":"21","author":"M Drey","year":"2020","unstructured":"Drey\u00a0M, Ferrari\u00a0U, Schraml\u00a0M et al (2020) German version of SARC-F: translation, adaption, and validation. J\u00a0Am Med Dir Assoc 21:747\u2013751","journal-title":"J Am Med Dir Assoc"},{"key":"1703_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jcsm.12444","volume":"10","author":"MA Perez-Sousa","year":"2019","unstructured":"Perez-Sousa\u00a0MA, Venegas-Sanabria\u00a0LC, Chavarro-Carvajal\u00a0DA et al (2019) Gait speed as a\u00a0mediator of the effect of sarcopenia on dependency in activities of daily living. J\u00a0Cachexia Sarcopenia Muscle 10:1009\u20131015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1703_CR14","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/jama.297.16.1772-b","volume":"297","author":"P Kortebein","year":"2007","unstructured":"Kortebein\u00a0P, Ferrando\u00a0A, Lombeida\u00a0J et\u00a0al (2007) Effect of 10\u00a0days of bed rest on skeletal muscle in healthy older adults. JAMA 297:1772\u20131774","journal-title":"JAMA"},{"key":"1703_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.arr.2013.07.003","volume":"12","author":"BT Wall","year":"2013","unstructured":"Wall\u00a0BT, Dirks\u00a0ML, van Loon\u00a0LJC (2013) Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia. Ageing Res Rev 12:898\u2013906","journal-title":"Ageing Res Rev"},{"key":"1703_CR16","first-page":"9","volume":"71","author":"A Othaka","year":"2019","unstructured":"Othaka\u00a0A, Aoki\u00a0H, Nagata\u00a0M et al (2019) Sarcopenia is a\u00a0poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy. Prostate Int 71:9\u201314","journal-title":"Prostate Int"},{"key":"1703_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","volume":"195","author":"H Fukushima","year":"2016","unstructured":"Fukushima\u00a0H, Nakanishi\u00a0Y, Kataoka\u00a0M et\u00a0al (2016) Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J\u00a0Urol 195:26\u201332","journal-title":"J Urol"},{"key":"1703_CR18","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/ijms19102999","volume":"19","author":"H Fukushima","year":"2018","unstructured":"Fukushima\u00a0H, Takemura\u00a0K, Suzuki\u00a0H et\u00a0al (2018) Impact of sarcopenia as a\u00a0prognostic biomarker of bladder cancer. Int J Mol Sci 19:2999\u20133007","journal-title":"Int J Mol Sci"},{"key":"1703_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/BLC-180188","volume":"29","author":"KJ Rimar","year":"2018","unstructured":"Rimar\u00a0KJ, Glaser\u00a0AP, Kundu\u00a0S et al (2018) Changes in lean muscle mass associated with neoadjuvant platinum-based chemotherapy in patients with muscle invasive bladder cancer. Bladder Cancer 29:411\u2013418","journal-title":"Bladder Cancer"},{"key":"1703_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.urology.2020.05.104","volume":"145","author":"DR Kaye","year":"2020","unstructured":"Kaye\u00a0DR, Schafer\u00a0C, Thelen-Perry\u00a0S et al (2020) The feasibility and impact of a presurgical exercise intervention program (prehabilitation) for patients undergoing cystectomy for bladder cancer. Urology 145:106\u2013112","journal-title":"Urology"},{"key":"1703_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.05.001","author":"HL Robertson","year":"2020","unstructured":"Robertson\u00a0HL, Michel\u00a0C, Bartl\u00a0L et\u00a0al (2020) Sarcopenia in urologic oncology: identification and strategies to improve patient outcomes. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.001","journal-title":"Urol Oncol"},{"key":"1703_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcsm.12279","volume":"9","author":"R Mayr","year":"2018","unstructured":"Mayr\u00a0R, Gierth\u00a0M, Zeman\u00a0F et al (2018) Sarcopenia as a\u00a0comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. J\u00a0Cachexia Sarcopenia Muscle 9:505\u2013513","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1703_CR23","first-page":"36","volume":"9","author":"A Pycha","year":"2020","unstructured":"Pycha\u00a0A, Comploj\u00a0E, Bonatti\u00a0M et\u00a0al (2020) Sarkopenie als Surrogatmarker f\u00fcr Gebrechlichkeit. UroNes 9:36\u201340","journal-title":"UroNes"},{"key":"1703_CR24","first-page":"6","volume":"13","author":"DK Layman","year":"2009","unstructured":"Layman\u00a0DK (2009) Dietary Guidelines should reflect new understandings about adult protein needs. Nutr Metab (Lond) 13:6\u201312","journal-title":"Nutr Metab (Lond)"},{"key":"1703_CR25","first-page":"1267","volume":"10","author":"S Goisser","year":"2015","unstructured":"Goisser\u00a0S, Kemmler\u00a0W, Porzel\u00a0S et\u00a0al (2015) Sarcopenic obesity and complex interventions with nutrition and exercise in communitydwelling older persons\u2014a narrative review. Clin Interv Aging 10:1267\u20131282","journal-title":"Clin Interv Aging"},{"key":"1703_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2174\/1381612821666150130122032","volume":"21","author":"AM Martone","year":"2015","unstructured":"Martone\u00a0AM, Lattanzio\u00a0F, Abbatecola\u00a0AM et\u00a0al (2015) Treating sarcopenia in older and oldest old. Curr Pharm Des 21:1715\u20131722","journal-title":"Curr Pharm Des"},{"key":"1703_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1891\/0198-8794.36.205","volume":"36","author":"TD Law","year":"2016","unstructured":"Law\u00a0TD, Clark\u00a0LA, Clark\u00a0BC (2016) Resistance exercise to prevent and manage sarcopenia and dynapenia. Annu Rev Gerontol Geriatr 36:205\u2013228","journal-title":"Annu Rev Gerontol Geriatr"},{"key":"1703_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1113\/jphysiol.2006.110742","volume":"575","author":"I Rieu","year":"2006","unstructured":"Rieu\u00a0I, Balage\u00a0M, Sornet\u00a0C et\u00a0al (2006) Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. J\u00a0Physiol 575:305\u2013315","journal-title":"J Physiol"},{"key":"1703_CR29","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/jc.2008-1564","volume":"94","author":"ED Dillon","year":"2009","unstructured":"Dillon\u00a0ED, Sheffield-Moore\u00a0M, Paddon-Jones\u00a0D et al (2009) Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor\u2011I expression in older women. J\u00a0Clin Endocrinol Metab 94:1630\u20131637","journal-title":"J Clin Endocrinol Metab"},{"key":"1703_CR30","first-page":"6","volume":"13","author":"E Kiesswetter","year":"2015","unstructured":"Kiesswetter\u00a0E (2015) Optimierte Ern\u00e4hrung bei Sarkopenie. Schweiz Z Ern\u00e4hrungsmed 13:6\u201311","journal-title":"Schweiz Z Ern\u00e4hrungsmed"},{"key":"1703_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/cpf.12117","volume":"34","author":"Y Watanabe","year":"2013","unstructured":"Watanabe\u00a0Y, Madarame\u00a0H, Ogasawara\u00a0R et al (2013) Effect of very low-intensity resistance training with slow movement on muscle size and strength in healthy older adults. Clin Physiol Funct Imaging 34:463\u2013470","journal-title":"Clin Physiol Funct Imaging"},{"key":"1703_CR32","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00198-010-1371-6","volume":"22","author":"DL Belavy","year":"2011","unstructured":"Belavy\u00a0DL, Beller\u00a0G, Armbrecht\u00a0G et al (2011) Evidence for an additional effect of whole-body vibration above resistive exercise alone in preventing bone loss during prolonged bed rest. Osteoporos Int 22:1581\u20131591","journal-title":"Osteoporos Int"},{"key":"1703_CR33","doi-asserted-by":"publisher","first-page":"109013","DOI":"10.1155\/2012\/109013","volume":"2012","author":"W Kemmler","year":"2012","unstructured":"Kemmler\u00a0W, von Stengel\u00a0S (2012) Alternative exercise technologies to fight against sarcopenia at old age: a series of studies and review. J\u00a0Aging Res 2012:109013. https:\/\/doi.org\/10.1155\/2012\/109013","journal-title":"J Aging Res"},{"key":"1703_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1532-5415.2010.03285.x","volume":"59","author":"EP Brass","year":"2011","unstructured":"Brass\u00a0EP, Sietsema\u00a0KE (2011) Considerations in the development of drugs to treat sarcopenia. J\u00a0Am Geriatr Soc 59:530\u2013535","journal-title":"J Am Geriatr Soc"},{"key":"1703_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40266-017-0444-z","volume":"34","author":"AJ Kilsby","year":"2017","unstructured":"Kilsby\u00a0AJ, Sayer\u00a0AA, Witham\u00a0MD (2017) Selecting potential pharmacological interventions in sarcopenia. Drugs Aging 34:233\u2013240","journal-title":"Drugs Aging"},{"key":"1703_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1574884708666131111192845","volume":"9","author":"H Wakabayashi","year":"2014","unstructured":"Wakabayashi\u00a0H, Sakuma\u00a0K (2014) Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol 9:171\u2013180","journal-title":"Curr Clin Pharmacol"},{"key":"1703_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","volume":"3","author":"C Becker","year":"2015","unstructured":"Becker\u00a0C, Lord\u00a0SR, Studenski\u00a0SA et al (2015) Myostatin antibody (LY2495655) in older weak fallers: a\u00a0proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3:948\u2013957","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1703_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/SPC.0000000000000013","volume":"74","author":"RC Smith","year":"2013","unstructured":"Smith\u00a0RC, Lin\u00a0BK (2013) Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Curr Opin Support Palliat Care 74:352\u2013360","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01703-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-021-01703-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01703-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T11:03:42Z","timestamp":1642417422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-021-01703-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s00120-021-01703-5","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"12 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.J.\u00a0Heppner und H.\u00a0Hag geben an, dass kein Interessenkonflikt besteht. Forschungsunterst\u00fctzung von ThermoScience, Forschungskolleg Geriatrie der Robert-Bosch-Stiftung, Wissenschaftsforum Geriatrie, Deutsche Bank, Innovationsfonds des GBA; Vortragshonorare von Pfizer Pharma, Bayer Health Care, Bayrische Landes\u00e4rztekammer (M\u00fcnchen), AO Trauma Europe, Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}